Biomea Fusion BMEA
NASDAQ BMEA
$1.77 +0.06 (+3.51%)
As of: Sep 22, 2026 · 10:24 AM EDT

Biomea Fusion (BMEA) Research & Development (2020 - 2026)

Biomea Fusion's (BMEA) quarterly Research & Development came in at $9.1 million in Q2 2026, down 44.81% year-over-year from $16.6 million in Q2 2025, and little changed quarter-over-quarter from $9.1 million in Q1 2026.

Analysis

Biomea Fusion (BMEA) Research & Development (2020 - 2026) Analysis & Trends

Biomea Fusion has disclosed Research & Development across 7 years of filings, most recently posting $9.1 million for Q2 2026.

  • In Q2 2026, Research & Development fell 44.81% year-over-year to $9.1 million; the TTM figure through Jun 2026 stood at $40.8 million (down 55.65% YoY), while the FY2025 annual figure was $62.0 million, down 47.51% from the prior year.
  • Research & Development came in at $9.1 million for Q2 2026 at Biomea Fusion, roughly flat from $9.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $33.8 million in Q1 2024 to a low of $8.1 million in Q4 2025.
  • Average Research & Development over 5 years is $20.2 million, with a median of $21.2 million recorded in 2022.
  • Year-over-year, Research & Development soared 198.84% in 2022 and tumbled 67.85% in 2025.
  • Over 5 years, Research & Development stood at $20.5 million in 2022, then surged by 50.28% to $30.9 million in 2023, then retreated by 18.23% to $25.2 million in 2024, then plunged by 67.85% to $8.1 million in 2025, then grew by 12.66% to $9.1 million in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $9.1 million in Q2 2026, $9.1 million in Q1 2026, and $8.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 3.65 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 2.34 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -2.85 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 2.81 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 2.96 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -2.60 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 394.92 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 612.28 Mn
10 Biomea Fusion 132.65 Mn 132.65 Mn - 9.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.14 Mn
Mar 31, 2026 9.12 Mn
Dec 31, 2025 8.12 Mn
Sep 30, 2025 14.40 Mn
Jun 30, 2025 16.57 Mn
Mar 31, 2025 22.90 Mn
Dec 31, 2024 25.24 Mn
Sep 30, 2024 27.24 Mn
Jun 30, 2024 31.83 Mn
Mar 31, 2024 33.78 Mn
Dec 31, 2023 30.87 Mn
Sep 30, 2023 25.35 Mn
Jun 30, 2023 21.94 Mn
Mar 31, 2023 24.40 Mn
Dec 31, 2022 20.54 Mn
Sep 30, 2022 18.24 Mn
Jun 30, 2022 12.58 Mn
Mar 31, 2022 11.35 Mn
Dec 31, 2021 11.09 Mn
Sep 30, 2021 7.89 Mn
API Access

Biomea Fusion Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=BMEA&period=max&api_key=YOUR_API_KEY